Patients | Age of onset | Age of follow up | Sex | Cerebral atrophy | Cerebellar atrophy | Cerebral calcification | Location of cerebral calcifications | Cerebellar calcification | Location of cerebellar calcifications |
---|---|---|---|---|---|---|---|---|---|
1 | 6 m | 3y (Ϯ) | M | ||||||
2 | 6w | 10y | M | ||||||
3 | 5w | 5y | F | Loss of subcortical WM volume | |||||
4 | 72d | 18 m | M | ||||||
5 | 9 m | M | |||||||
6 | 18 m | 14y | F | ||||||
7 | 1y | 26y | F | ||||||
8 | 1y | 21y | M | ||||||
9 | 1 m | 18y | F | Y(2y) | |||||
10 | 1 m | 15y | F | ||||||
11 | 3 m | 19 m | M | Y | Thalami, anterior commissure, anterior arms of the internal capsules, along the opticall pathways, midbrain | Y | Cerebellar dentate nuclei | ||
12 | 6 m | 7y | M | Y(3y) | Y(7Y) | Y(3y) | Periventricular WM, paons, thalami, internal capsules and calcarine cortex | Y | Cerebellar WM |
13 | 6 m | 18 m | F | y(6 m) | Y | Internal capsules, deep and periventricular WM | |||
14 | 28y | 33y (Ϯ) | F | ||||||
15 | Birth | 12y (Ϯ) | M | Y(nascita at birth) | WM | ||||
16 | Birth | 2y (Ϯ) | M | Low density of WM | y(2y) | ||||
17 | Birth | 4y (Ϯ) | M | y(3y) | Internal capsule | ||||
18 | Birth | 8y (Ϯ) | M | Low density of WM | y(nascita at birth) | ||||
19 | Birth | 12y | M | Low density of WM | y(nascita at birth) | ||||
20 | Birth | 12y (Ϯ) | M | Low density of WM | y(2y) | Internal capsule | |||
21 | Birth | 3y | M | ||||||
22 | 25y | 27y (Ϯ) | F | ||||||
23 | 15y | 35y | M | ||||||
24 | 35y | 32y | M | ||||||
25 | Birth | 3y | M | Y | Cerebellar nuclei | ||||
26 | Birth | 12y (Ϯ) | F | Y (cerebellar white loss) | Y | Basal ganglia, frontal, parietal lobes | |||
27 | Birth | 30 m (Ϯ) | F | Y | Y | Y | Semioval center, corona radiata, periventricular WM, thalamus, brainstem | Y | Dentate nucleus |
Patients | Spinal calcification | Location of spinal calcifications | WM abnormalities | MRI spectroscopy | Repiratory chain | Histological muscle biopsy | Plasmatic organic acids and aminoacids | Cerebrospinal fluid biogenic amines | Liver | Deafness |
---|---|---|---|---|---|---|---|---|---|---|
1 | Increased mtDNA in muscle | ↑lactate and alanine | Y | |||||||
2 | Deep WM | |||||||||
3 | ||||||||||
4 | ||||||||||
5 | I, IV | ↑lactate | ||||||||
6 | IV, I + IV | |||||||||
7 | Frontal WM, corpus callosum | Y | ||||||||
8 | Periventricular WM, corpus callosum | Y | ||||||||
9 | Y | |||||||||
10 | Y | |||||||||
11 | Y | Tracl-like calcifications along the medullary pathways | U-fibers, internal and external capsules, brainstem, cerebellum | ↑lactate and lipids, ↑choline/creatine, ↑myoinositol/creatine, ↓N-acetylaspartate/creatine | I, II, I + III, II + III | normal | Moderate ketosis,↑ alanin | Biopterin | Y | |
12 | Y | C6-T1 | Deep cerebellum WM, middle cerebellar peduncles, brainstem, U-fiber, posterior arm of the internal and external capsules, thalami | ↓N-acetylaspartate, ↑ lactate | ↑lactate and pyruvate | Hepatomegaly, ↑ transaminase | Y(profound) | |||
13 | Y(12 m) | Dentate nuclei | Centrum semiovale, corona radiata, posterior arm of the internal and external capsules, thalami, cerebellar amd deep WM and brainstem, V cranial nerves, cervical and dorsal columns | ↑lactate and pyruvate | ↑ transaminase, vascular disturbance with nodular regenerative hyperplasia | Y | ||||
14 | Dentate nucleus, optic radiations, corpus callosum splenium | I,IV | COX-neg fibers | ↑lactate | Y | |||||
15 | Posterior limbs of the internal capsules, thalami | Y | ||||||||
16 | Y(2y) | Y | ||||||||
17 | Precentral gyri | ↑lactate | Y | |||||||
18 | Y | ↑lactate and pyruvate | Y | |||||||
19 | Y | ↑lactate and pyruvate | Y | |||||||
20 | Internal capsules | ↑lactate in cerebral WM | Y | |||||||
21 | Y (and atrophy) | Y | ||||||||
22 | Inner capsule | Y | ||||||||
23 | Periventricular WM | Y | ||||||||
24 | Y | |||||||||
25 | Abnormal ultrasound | Y | ||||||||
26 | Deep WM of both cerebral hemispheres, corticospinal tracts | ↑lactate | ↑proteins | Y | ||||||
27 | ↓NAA/Cr ratio, ↓ Cho/Cr ratio, presence of lactate | I + III, IV | ↑lactate and glycine | Cirrhotic hepatopathy, polylobulated liver aspect, presence of bleeding esophageal varices, liver calcifications | Y |
Patients | CNS | Microcephaly | Hemato | Seizures | Ocular | Scoliosis | Heart | Others | Allele1 | Allele2 | Author |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | Development delay, hypotonia, dystonia | Strabism, ophtalmoplegia | c.1760C>T p.Thr587Met | c.683C>T p.Pro228Leu | Lieber (2013) Neurology 80, 1762 | ||||||
2 | Y | Y | Nystagmus, delayed PEV | c.1396C>T p.Arg466Trp | c.1657G>A p.Glu553Lys | McMillan (2015) J Child Neurol 30, 1037 | |||||
3 | c.1396C>T p.Arg466Trp | c.1657G>A p.Glu553Lys | McMillan (2015) J Child Neurol 30, 1037 | ||||||||
4 | Hypertonicity, extreme irritability, psychomotor delay | Y | Y (West sindrome) | Nystagmus, abnomal ocular movements | Failure to thrive | c.169G>C p.Ala57Pro | chr16: 75,672,800–75,680,400 loss of starting codon | Joshi C. (2016) Biomed Res Int. 2016:6,421,039 | |||
5 | Development delay | Y | Nystagmus | Hypertrophic cardiomyopathy | c.1427T>A p.Val476Asp | c.1037T>C p.Ile346Thr | Kohda (2016) PLoS Genet 12, e1005679 | ||||
6 | Mild psychomotor delay, intellectual disability, mild myopathy | Hypertrophic cardiomyopathy | c.1133T>A p.Leu378Hys | c.1253C>G p.Pro418Arg | Verrigni (2017) Clin Genet 91, 918 | ||||||
7 | Progressiv ecognitive impairment | c.1514G>A p.Arg505Hys | c.1597C>T p.Pro533Ser | Zhou (2017) Hum Mutat 38, 1740 | |||||||
8 | Progressiv ecognitive impairment | c.1514G>A p.Arg505Hys | c.1597C>T p.Pro533Ser | Zhou (2017) Hum Mutat 38, 1740 | |||||||
9 | Development delay, hypotonia | Y | Y | c.1577C>T p.Ala526Val | c.1466T>G p.Phe489Cys | Murray (2017) J Pediatr Genet 6, 77 | |||||
10 | Development delay | Y | Y | c.1577C>T p.Ala526Val | c.1466T>G p.Phe489Cys | Murray (2017) J Pediatr Genet 6, 77 | |||||
11 | Severe spastic tetraplegia, progressive hypertonus, absense of voluntary movementes | Y | Hypertonic seizures | VEP and ERG mild conduction delay | c.1514G>A p.Arg505His | c.1514G>A p.Arg505His | Ardissone A (2018) Orphanet J Rare Dis 13(1):45 | ||||
12 | Absence of spontaneus movements and postural control, spastic tetraparesis with extrapyramidal signs, absence of language | Microcytic hypocromic anemia | Nystagmus, bilateral optic atrophy | Marked | c.1124A>G p.Tyr375Cys | c.381C>G p.Phe127Leu | Ardissone A (2018) Orphanet J Rare Dis 13(1):45 | ||||
13 | Spastic tetraplegia, absent postural control, poor spontaneus movements | Y | Microcytic hypocromic anemia | Delayed VEP, mild retinal depigmentation | c.815T>G p.Phe272Cys | c.1043G>A p.Arg348His | Ardissone (2018) Orphanet J Rare Dis 13(1):45 | ||||
14 | Cerebellar ataxia | Concentric decrease of peripheral isopter | c.683C>T p.Pro228Leu | c.871T>G p.Phe291Val | Scheidecker (2019) Hum Mutat 40, 1826 | ||||||
15 | Hypotonia, difficulty feeding, delayed development | Y | Nystagmus | c.1786C>T p.Leu596Phe | c.1786C>T p.Leu596Phe | Itoh (2019) Brain 142(3):560–573 | |||||
16 | Hypotonia, severe development delay | Anemia, thrombocytopenia, | Y | Nystagmus | Distal renal tubular acidosis | c.1786C>T p.Leu596Phe | c.879 + 1G>A p.Glu252_Glu293del | Itoh (2019) Brain 142(3):560–573 | |||
17 | Hypotonia, development delay | Y | Nystagmus | Distal renal tubular acidosis | c.1786C>T p.Leu596Phe | c.879 + 1G>A p.Glu252_Glu293del | Itoh (2019) Brain 142(3):560–573 | ||||
18 | Tetraplegia, development delay, hypotonia | Pancytopaenia | Y | Nystagmus | c.1786C>T p.Leu596Phe | c.1786C>T p.Leu596Phe | Itoh (2019) Brain 142(3):560–573 | ||||
19 | Hypertonia, tetraplegia, dystonia, hypotonia | Anemia | Y | c.1786C>T p.Leu596Phe | c.1786C>T p.Leu596Phe | Itoh (2019) Brain 142(3):560–573 | |||||
20 | Hypotonia, severe development delay | Y | Nystagmus | c.1786C>T p.Leu596Phe | c.1786C>T p.Leu596Phe | Itoh (2019) Brain 142(3):560–573 | |||||
21 | Hypotonia, chorea, spasticity | Anemia, hypogammaglobulinemia | Y | Nystagmus | c.1786C>T p.Leu596Phe | c.566G>A p.Gly189Asp | Itoh (2019) Brain 142(3):560–573 | ||||
22 | Hypotonia, intellectual disability, slurred speech, ataxia, abnormal movements | c.1514G>A p.Arg505His | c.1597C>T p. Pro533Ser | Sun (2019) Neurol Genet.5(2):e565 | |||||||
23 | c.1514G>A p.Arg505His | c.1597C>T p. Pro533Ser | Sun (2019) Neurol Genet.5(2):e565 | ||||||||
24 | Progressive neurocognitive decline, hypertonia, abnormal movements, ataxia | Y | Left eye blindness | Primary hypothyroidism | c.881T>C p.Ile294Thr | c.1760C>T p.Thr587Met | Sun (2019) Neurol Genet.5(2):e565 | ||||
25 | Developmente delay, development regression, hypertonia, hyperreflexia, progressive joint contractures, dysphagia | Y | Y | Vision loss, nystagmus | Renal tubular acidosis, mild monolateral hydronephrosis, failure to thrive | c.1281_1282insAGA p.Glu427_Leu428insAeg | c.1786C>T p.Leu596Phe | Sun (2019) Neurol Genet.5(2):e565 | |||
26 | Developmente delay, hypotonia, intellectual disability, development regression, ataxia | Y | c.697C>G p.Leu233Val | c.697C>G p.Leu233Val | Sun (2019) Neurol Genet.5(2):e565 | ||||||
27 | Apostural tetraparesis, severe development delay | Y | Pancitopenia, ring sideroblasts | Y | Leopard spot retinopathy, thin pRNF, retinal thinning, strabismus, poor fixation, delayed VEP | Pulmonary valve stenosis | Failure to thrive | c.815T>G p.Phe272Cys | c.1570T>C p.Cys524Arg | OUR PATIENT |